Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Arthritis and Rheumatism|April 3, 2008
Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibodyNorihiro Nishimoto, Hideko Nakahara, Naoko Yoshio-Hoshino, et al.
Arthritis Research & Therapy|April 19, 2011
Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosusHooi-Ming Lee, Hidehiko Sugino, Chieko Aoki, et al.
Annals of Nuclear Medicine|August 16, 2005
Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibodyKanji Sugimoto, Norihiro Nishimoto, Tadamitsu Kishimoto, et al.
Immunology Letters|November 5, 2002
Characterization of anti-mouse interleukin-6 receptor antibodyMakoto Okazaki, Yoshiki Yamada, Norihiro Nishimoto, et al.
Chemical & Pharmaceutical Bulletin|December 15, 2015
Comparisons of Aluminum and Silica Elution from Various Glass VialsToru Ogawa, Makoto Miyajima, Norihiro Nishimoto, et al.
American Journal of Neurodegenerative Disease|July 12, 2013
Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patientsMilan Fiala, Mathew T Mizwicki, Rachel Weitzman, et al.
Plos One|April 24, 2012
Effects of mechanical over-loading on the properties of soleus muscle fibers, with or without damage, in wild type and mdx miceMasahiro Terada, Fuminori Kawano, Takashi Ohira, et al.
Nephron. Experimental Nephrology|March 30, 2005
All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic miceYoshihito Shima, Masayuki Iwano, Kazuyuki Yoshizaki, et al.
Modern Rheumatology|May 3, 2011
Diagnostic features of mild cellulitis phlegmon in patients with rheumatoid arthritis treated with tocilizumab: a report of two casesMakoto Hirao, Akihide Nampei, Kenrin Shi, et al.
Blood|September 12, 2008
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman diseaseNorihiro Nishimoto, Kimio Terao, Toru Mima, et al.
Pageof 12